Abstract Details

Title Effect of Adding Milnacipran to Pregabalin for the Management of Fibromyalgia: A Randomized, Open-Label, Controlled Study

Topic Ethics, Pain and Palliative Care

Presentation(s) (-)

Poster/Presentation
Number 002

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
Joel M. Trugman, MD, FAAN	Dr. Trugman has received personal compensation for serving as an employee of AbbVie. Dr. Trugman has stock in AbbVie.
Lori A. Shutter, MD, FCCM, FNCS, FAAN, FAAN (UPMC Dept of Critical Care Medicine)	The institution of Dr. Shutter has received research support from NIH. Dr. Shutter has received publishing royalties from a publication relating to health care.
	No disclosure on file
R. Michael Gendreau	No disclosure on file
Joel Kramer, PhD (UCSF Medical Center)	The institution of Dr. Kramer has received research support from tau consortium. Dr. Kramer has received publishing royalties from a publication relating to health care.

��ɫ��